Latest Articles

Publication Date
Tamoxifen affects cell morphology and PI3K signaling in mouse... - researchgate.net

Tamoxifen affects cell morphology and PI3K signaling in mouse... researchgate.net

Published: Aug. 26, 2025, 3:54 a.m.
Rapamycin inhibits tamoxifen-induced endometrial proliferation in vitro as a pilot approach for endometrial protection in breast cancer - Nature.com

Rapamycin inhibits tamoxifen-induced endometrial proliferation in vitro as a pilot approach for endometrial protection in breast cancer Nature.com

Published: Jan. 16, 2025, 10:45 a.m.
Machine learning Nomogram for Predicting endometrial lesions after tamoxifen therapy in breast Cancer patients - Nature.com

Machine learning Nomogram for Predicting endometrial lesions after tamoxifen therapy in breast Cancer patients Nature.com

Published: Jan. 6, 2025, 3:49 p.m.
Recent Trends in Medical Management of Endometriosis.

Endometriosis affects about 10 percent women in the reproductive age group globally and approximately 42 million in India. Managing the patient's pain symptoms associated with endometriosis appears to be the …

Published: Dec. 26, 2024, midnight
Postmenopausal Endometriosis: Clinical Insights and Imaging Considerations.

Endometriosis is a chronic systemic condition characterized by the presence of ectopic endometrial-like tissue outside of the uterus. It occurs most often in reproductive-aged patients and less frequently in postmenopausal …

Published: Nov. 15, 2024, midnight
Postmarketing adverse events of tamoxifen in male and female patients with breast cancer.

Tamoxifen (TAM), a selective estrogen receptor (ER) modulator, has received approval for use in patients with breast cancer (BC) exhibiting positive ER expression. Given the widespread clinical use of TAM, …

Published: Sept. 21, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!